Motley Fool Press Release.
SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone disruptors, and pesticides—affect cells and the role Protandim® Nrf2 can play in helping protect against their impact.† These findings further reinforce LifeVantage’s position as a pioneer in nutrigenomics and t
SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products desi...
SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company’s President and Chief Executive Officer, under the Company’s 2026 New Employee Long-Term Incentive Plan. The awards were granted pursuant to the key executive benefits agreement between the Company and Mr. Moorehead, dated as of April 15, 2026, as an inducement material to
Lifevantage (NASDAQ:LFVN) executives outlined a turnaround plan centered on strengthening the company’s brand, improving consumer relevance and increasing operating efficiency during a Water Tower Research conference discussion. President and CEO Terrence Moorehead, who recently joined the company,
SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products d...
Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.
Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.
Detailed price information for Lifevantage Corp (LFVN-Q) from The Globe and Mail including charting and trades.
Moby summary of LifeVantage Corporation's Q4 2026 earnings call
Lifevantage (NASDAQ:LFVN) reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against prior-year sales of its MindBody GLP-1 System. For the fourth quarter ended June 30, net revenue declin
Lifevantage: Fiscal Q4 Earnings Snapshot
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026. Fourth Quarter Fiscal 2026 Summary*: Revenue was $42.4 million, a decrease of 23.1% from the prior year period;Revenue in the Americas decreased 24.8%, and revenue in Asia/Pacific & Europe decreased 16.9%;
LifeVantage (LFVN) reported Thursday Q4 adjusted earnings of $0.11 per diluted share, down from $0.1
New CEO outlines turnaround plan as subscription base remains resilient despite macroeconomic headwinds
SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026. About LifeVantage Corporation LifeVantage Cor
This is the newest page. Registered accounts read further back.